XBI

Risk Asset Update: Where Do We Go From Here?

Weren't lower oil prices supposed to act like a tax cut for U.S. households and stimulate the economy? Here's what's really going on... More 

IBB: Another Biotech Bloodbath Beckons

Biotech stocks are poised for another downturn. Profit with this IBB stock put spread. More 

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI. More 

What Deleveraging May Mean For Netflix…and You

Margin debt levels have lessened, and while that might sound like sound financial planning, the reasons suggest potential markets problems More 

Bet on a Bounce with These Biotech ETFs

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain. More 

Be Careful Before Loving Leveraged Biotech ETFs

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. More 

3 Charts That Tell Us About the Stock Market in October

The economy continues to struggle, employment is still weak, and markets are vulnerable. Here's how we're going to position our portfolio More